The MDM2 oncogene is rarely amplified in human lymphoid tumors and does not correlate with p53 gene expression

This publication has 10 references indexed in Scilit:

• Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations
  Blood, 1992
• Amplification of a gene encoding a p53-associated protein in human sarcomas
  Nature, 1992
• The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
  Cell, 1992
• p53 mutations in colorectal cancer.
  Proceedings of the National Academy of Sciences, 1990
• Increased expression of mutant forms of p53 oncogene in primary lung cancer
  The Lancet, 1990
• Stabilization of the p53 transformation-related protein in mouse fibrosarcoma cell lines: effects of protein sequence and intracellular environment.
  Molecular and Cellular Biology, 1989
• Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life.
  Molecular and Cellular Biology, 1988
• Detection of a second t(14;18) breakpoint cluster region in human follicular lymphomas.
  The Journal of Experimental Medicine, 1986
• Increased expression of p53 protein in human leukemia cells.
  Proceedings of the National Academy of Sciences, 1986
• A monoclonal antibody detecting the adenovirus type 5 E 1 b-58Kd tumor antigen: Characterization of the E 1 b-58Kd tumor antigen in adenovirus-infected and -transformed cells
  Virology, 1982